Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

VU-0453595 shows potential for schizophrenia in a mouse model

Nov. 20, 2014

Investigators develop DNA-based vaccine against Leishmaniasis infection

Nov. 19, 2014

Preclinical pharmacology, safety and activity profiling of dual JAK3/ITK inhibitor ARN-4079

Nov. 19, 2014

P-11520031, a novel T-type calcium channel blocker for neuropathic pain

Nov. 19, 2014

RALDH 1 explored as a target for treating obesity and diabetes

Nov. 19, 2014

First possible biomarker for liver disease in alpha-1 antitypsin deficiency identified

Nov. 19, 2014

Validation of the antifibrogenic activity of a peripherally restricted CB1 antagonist

Nov. 19, 2014

Tumor antigen-targeted IL-15 complex eliminates lymphoma cells

Nov. 18, 2014

Genetic variant linked to intracranial major artery stenosis/occlusion

Nov. 18, 2014

Phase I results of a tetravalent purified inactivated dengue vaccine

Nov. 18, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...